Publications by authors named "Peny Retsa"

Claim this Profile
C
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
Oliver A Cornely, Dilip Nathwani, Cristina Ivanescu, Olatunji Odufowora-Sita, Peny Retsa

J Antimicrob Chemother· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection.
Dilip Nathwani, Oliver A Cornely, Anke K Van Engen, Olatunji Odufowora-Sita, Peny Retsa

J Antimicrob Chemother· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
Warren Mark Hart, Paul Abrams, Vicki Munro, Peny Retsa, Jameel Nazir

J Med Econ· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.
Jaro Wex, Manpreet Sidhu, Isaac Odeyemi, Ahmed M Abou-Setta, Peny Retsa

Clinicoecon Outcomes Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deriving health state utilities for the numerical pain rating scale.
Simon Dixon, Chris D Poole, Isaac Odeyemi, Peny Retsa, Colette Chambers

Health Qual Life Outcomes· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis